Our analysis confirmed that SMYD5 is overexpressed in LIHC tissues compared to adjacent normal tissues, as established through immunohistochemical staining and protein expression profiling using data from the Human Protein Atlas (HPA) and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) (Figure 3a,b). This evidence concerns the gene SMYD5 and neoplasm.